Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
20.43
+0.60 (3.03%)
At close: Sep 18, 2026, 4:00 PM EDT
20.73
+0.30 (1.47%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Omada Health Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Omada Health stock has a consensus rating of "Buy" and an average price target of $28.42. The average 1-year stock price forecast is 39.11% higher than the current stock price, while the lowest is $22 (+7.68%) and the highest is $35 (+71.32%).
Price Target: $28.42 (+39.11%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $22 | Hold | Maintains | $22 | +7.68% | Sep 15, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Reiterates $35 | Buy | Reiterates | $35 | +71.32% | Sep 14, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $25 | Buy | Maintains | $25 | +22.37% | Sep 11, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $24 | Buy | Reiterates | $24 | +17.47% | Sep 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $28 | Buy | Reiterates | $28 | +37.05% | Sep 11, 2026 |
Financial Forecast
Revenue This Year
338.66M
from 260.21M
Increased by 30.15%
Revenue Next Year
407.80M
from 338.66M
Increased by 20.42%
EPS This Year
0.44
from 0.15
Increased by 181.49%
EPS Next Year
0.56
from 0.44
Increased by 27.56%
EPS and Forward PE are based on non-GAAP adjusted numbers.